<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                Part 201: Labeling
                            </h3>
                            <table>
  <thead>
    <tr>
      <th scope="col">Section No.</th>
      <th scope="col">Description</th>
    </tr>
  </thead>
  <tbody>
    
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.1.html">
                        Section 201.1
                        </a>
                  </td>
                  <td scope="row">Drugs; name and place of business of manufacturer, packer, or distributor</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.2.html">
                        Section 201.2
                        </a>
                  </td>
                  <td scope="row">Drugs and devices; National Drug Code numbers</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.5.html">
                        Section 201.5
                        </a>
                  </td>
                  <td scope="row">Drugs; adequate directions for use</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.6.html">
                        Section 201.6
                        </a>
                  </td>
                  <td scope="row">Drugs; misleading statements</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.10.html">
                        Section 201.10
                        </a>
                  </td>
                  <td scope="row">Drugs; statement of ingredients</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.15.html">
                        Section 201.15
                        </a>
                  </td>
                  <td scope="row">Drugs; prominence of required label statements</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.16.html">
                        Section 201.16
                        </a>
                  </td>
                  <td scope="row">Drugs; Spanish-language version of certain required statements</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.17.html">
                        Section 201.17
                        </a>
                  </td>
                  <td scope="row">Drugs; location of expiration date</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.18.html">
                        Section 201.18
                        </a>
                  </td>
                  <td scope="row">Drugs; significance of control numbers</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.19.html">
                        Section 201.19
                        </a>
                  </td>
                  <td scope="row">Drugs; use of term ``infant''</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.20.html">
                        Section 201.20
                        </a>
                  </td>
                  <td scope="row">Declaration of presence of FD&C; Yellow No</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.21.html">
                        Section 201.21
                        </a>
                  </td>
                  <td scope="row">Declaration of presence of phenylalanine as a component of aspartame in over-the-counter and prescription drugs for human use</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.22.html">
                        Section 201.22
                        </a>
                  </td>
                  <td scope="row">Prescription drugs containing sulfites; required warning statements</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.23.html">
                        Section 201.23
                        </a>
                  </td>
                  <td scope="row">Required pediatric studies</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.24.html">
                        Section 201.24
                        </a>
                  </td>
                  <td scope="row">Labeling for systemic antibacterial drug products</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.25.html">
                        Section 201.25
                        </a>
                  </td>
                  <td scope="row">Bar code label requirements</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.26.html">
                        Section 201.26
                        </a>
                  </td>
                  <td scope="row">Exceptions or alternatives to labeling requirements for human drug products held by the Strategic National Stockpile</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.50.html">
                        Section 201.50
                        </a>
                  </td>
                  <td scope="row">Statement of identity</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.51.html">
                        Section 201.51
                        </a>
                  </td>
                  <td scope="row">Declaration of net quantity of contents</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.55.html">
                        Section 201.55
                        </a>
                  </td>
                  <td scope="row">Statement of dosage</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.56.html">
                        Section 201.56
                        </a>
                  </td>
                  <td scope="row">Requirements on content and format of labeling for human prescription drug and biological products</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.57.html">
                        Section 201.57
                        </a>
                  </td>
                  <td scope="row">Specific requirements on content and format of labeling for human prescription drug and biological products described in</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.57.html">
                        Section 201.57
                        </a>
                  </td>
                  <td scope="row">Specific requirements on content and format of labeling for human prescription drug and biological products described</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.58.html">
                        Section 201.58
                        </a>
                  </td>
                  <td scope="row">Waiver of labeling requirements</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.60.html">
                        Section 201.60
                        </a>
                  </td>
                  <td scope="row">Principal display panel</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.61.html">
                        Section 201.61
                        </a>
                  </td>
                  <td scope="row">Statement of identity</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.62.html">
                        Section 201.62
                        </a>
                  </td>
                  <td scope="row">Declaration of net quantity of contents</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.63.html">
                        Section 201.63
                        </a>
                  </td>
                  <td scope="row">Pregnancy/breast-feeding warning</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.64.html">
                        Section 201.64
                        </a>
                  </td>
                  <td scope="row">Sodium labeling</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.66.html">
                        Section 201.66
                        </a>
                  </td>
                  <td scope="row">Format and content requirements for over-the-counter (OTC) drug product labeling</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.70.html">
                        Section 201.70
                        </a>
                  </td>
                  <td scope="row">Calcium labeling</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.71.html">
                        Section 201.71
                        </a>
                  </td>
                  <td scope="row">Magnesium labeling</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.72.html">
                        Section 201.72
                        </a>
                  </td>
                  <td scope="row">Potassium labeling</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.80.html">
                        Section 201.80
                        </a>
                  </td>
                  <td scope="row">Specific requirements on content and format of labeling for human prescription drug and biological products; older drugs not</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.100.html">
                        Section 201.100
                        </a>
                  </td>
                  <td scope="row">Prescription drugs for human use</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.105.html">
                        Section 201.105
                        </a>
                  </td>
                  <td scope="row">Veterinary drugs</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.115.html">
                        Section 201.115
                        </a>
                  </td>
                  <td scope="row">New drugs or new animal drugs</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.116.html">
                        Section 201.116
                        </a>
                  </td>
                  <td scope="row">Drugs having commonly known directions</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.117.html">
                        Section 201.117
                        </a>
                  </td>
                  <td scope="row">Inactive ingredients</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.119.html">
                        Section 201.119
                        </a>
                  </td>
                  <td scope="row">In vitro diagnostic products</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.120.html">
                        Section 201.120
                        </a>
                  </td>
                  <td scope="row">Prescription chemicals and other prescription components</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.122.html">
                        Section 201.122
                        </a>
                  </td>
                  <td scope="row">Drugs for processing, repacking, or manufacturing</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.125.html">
                        Section 201.125
                        </a>
                  </td>
                  <td scope="row">Drugs for use in teaching, law enforcement, research, and analysis</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.127.html">
                        Section 201.127
                        </a>
                  </td>
                  <td scope="row">Drugs; expiration of exemptions</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.128.html">
                        Section 201.128
                        </a>
                  </td>
                  <td scope="row">Meaning of ``intended uses''</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.129.html">
                        Section 201.129
                        </a>
                  </td>
                  <td scope="row">Drugs; exemption for radioactive drugs for research use</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.150.html">
                        Section 201.150
                        </a>
                  </td>
                  <td scope="row">Drugs; processing, labeling, or repacking</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.161.html">
                        Section 201.161
                        </a>
                  </td>
                  <td scope="row">Carbon dioxide and certain other gases</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.200.html">
                        Section 201.200
                        </a>
                  </td>
                  <td scope="row">Disclosure of drug efficacy study evaluations in labeling and advertising</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.300.html">
                        Section 201.300
                        </a>
                  </td>
                  <td scope="row">Notice to manufacturers, packers, and distributors of glandular preparations</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.301.html">
                        Section 201.301
                        </a>
                  </td>
                  <td scope="row">Notice to manufacturers, packers, and distributors of estrogenic hormone preparations</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.302.html">
                        Section 201.302
                        </a>
                  </td>
                  <td scope="row">Notice to manufacturers, packers, and distributors of drugs for internal use which contain mineral oil</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.303.html">
                        Section 201.303
                        </a>
                  </td>
                  <td scope="row">Labeling of drug preparations containing significant proportions of wintergreen oil</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.304.html">
                        Section 201.304
                        </a>
                  </td>
                  <td scope="row">Tannic acid and barium enema preparations</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.305.html">
                        Section 201.305
                        </a>
                  </td>
                  <td scope="row">Isoproterenol inhalation preparations (pressurized aerosols, nebulizers, powders) for human use; warnings</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.306.html">
                        Section 201.306
                        </a>
                  </td>
                  <td scope="row">Potassium salt preparations intended for oral ingestion by man</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.307.html">
                        Section 201.307
                        </a>
                  </td>
                  <td scope="row">Sodium phosphates; package size limitation, warnings, and directions for over-the-counter sale</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.308.html">
                        Section 201.308
                        </a>
                  </td>
                  <td scope="row">Ipecac syrup; warnings and directions for use for over-the-counter sale</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.309.html">
                        Section 201.309
                        </a>
                  </td>
                  <td scope="row">Acetophenetidin (phenacetin)-containing preparations; necessary warning statement</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.310.html">
                        Section 201.310
                        </a>
                  </td>
                  <td scope="row">Phenindione; labeling of drug preparations intended for use by man</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.312.html">
                        Section 201.312
                        </a>
                  </td>
                  <td scope="row">Magnesium sulfate heptahydrate; label declaration on drug products</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.313.html">
                        Section 201.313
                        </a>
                  </td>
                  <td scope="row">Estradiol labeling</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.314.html">
                        Section 201.314
                        </a>
                  </td>
                  <td scope="row">Labeling of drug preparations containing salicylates</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.315.html">
                        Section 201.315
                        </a>
                  </td>
                  <td scope="row">Over-the-counter drugs for minor sore throats; suggested warning</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.316.html">
                        Section 201.316
                        </a>
                  </td>
                  <td scope="row">Drugs with thyroid hormone activity for human use; required warning</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.317.html">
                        Section 201.317
                        </a>
                  </td>
                  <td scope="row">Digitalis and related cardiotonic drugs for human use in oral dosage forms; required warning</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.319.html">
                        Section 201.319
                        </a>
                  </td>
                  <td scope="row">Water-soluble gums, hydrophilic gums, and hydrophilic mucilloids (including, but not limited to agar, alginic acid, calcium</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.320.html">
                        Section 201.320
                        </a>
                  </td>
                  <td scope="row">Warning statements for drug products containing or manufactured with chlorofluorocarbons or other ozone-depleting</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.323.html">
                        Section 201.323
                        </a>
                  </td>
                  <td scope="row">Aluminum in large and small volume parenterals used in total parenteral nutrition</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.325.html">
                        Section 201.325
                        </a>
                  </td>
                  <td scope="row">Over-the-counter drugs for vaginal contraceptive and spermicide use containing nonoxynol 9 as the active ingredient; required</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.326.html">
                        Section 201.326
                        </a>
                  </td>
                  <td scope="row">Over-the-counter drug products containing internal analgesic/antipyretic active ingredients; required warnings and</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="../sections/21CFR201.327.html">
                        Section 201.327
                        </a>
                  </td>
                  <td scope="row">Over-the-counter sunscreen drug products; required labeling based on effectiveness testing</td>
                </tr>
                
  </tbody>
</table>

      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ❤ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
